XFOR Stock Summary and Trading Ideas (X4 Pharmaceuticals | NASDAQ:XFOR)

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

What symbol and exchange does X4 Pharmaceuticals shares trade?

X4 Pharmaceuticals trades on the NASDAQ stock market under the symbol XFOR.

What is X4 Pharmaceuticals stock price doing today?

As of December 31, 2025, XFOR stock price declined to $4.00 with 317,869 million shares trading.

What is X4 Pharmaceuticals's Beta?

XFOR has a beta of 0.80, meaning it tends to be less sensitive to market movements. XFOR has a correlation of 0.01 to the broad based SPY ETF.

How much is X4 Pharmaceuticals worth?

XFOR has a market cap of $349.75 million. This is considered a Small Cap stock.

How much money does X4 Pharmaceuticals make?

Last quarter X4 Pharmaceuticals reported $2 million in Revenue and -$.69 earnings per share. This fell short of revenue expectation by $-136,350 and exceeded earnings estimates by $.13.

What is the highest and lowest price X4 Pharmaceuticals traded in the last 3 year period?

In the last 3 years, XFOR traded as high as $77.25 and as low as $1.35.

What are the top ETFs holding X4 Pharmaceuticals?

The top ETF exchange traded funds that XFOR belongs to (by Net Assets): VTI, VXF, MSSM, ITWO, URTY.

Is X4 Pharmaceuticals (XFOR) a good investment?

XFOR has underperformed the market in the last year with a return of -81.8%, while SPY returned +17.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XFOR shares. However, XFOR has outperformed the market in the last 3 month and 2 week periods, returning +17.0% and +14.0%, while SPY returned +2.7% and +1.9%, respectively. This indicates XFOR has been having a stronger performance recently.

What are the support and resistance levels for X4 Pharmaceuticals (XFOR)?

XFOR support price is $3.91 and resistance is $4.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XFOR shares will trade within this expected range on the day.